- Jul. 17, 2014 - ST. LOUIS --
The publisher of websites about aging and prescription medicine issues has sent a letter to Sylvia Mathews Burwell, recently approved as Secretary of Health and Human Services (HHS) alerting her that unless she takes action, Americans may witness the spectacle of a governmental agency (the FDA) specifically designed to protect and promote the health and well-being of Americans destroying personally imported legitimate brand-name medicines at a time when millions of citizens are unable to enjoy the health benefits of access to a regimen of prescription medicines because of their high cost.
Daniel Hines, Publisher of www.TodaysSeniorsNetwork.com (http://www.todaysseniorsnetwork.com/)
and http://RxforAmericanHealth.blogpot.com (http://rxforamericanhealth.blogspot.com/)
, said he sent the letter in response to the rules promulgation process of the FDA for Section 708 of the Food and Drug Administration Safety and Innovation Act (FDASIA) which would allow the destruction of a drug valued at $2,500 or less that has been refused admission into the United States.
“Since there is no requirement that the FDA test the authenticity of seized medicines, we can be certain that authentic, safe affordable prescription brand-name medicines personally imported by U.S. citizens from licensed, registered pharmacies in Tier One Countries, whose standards of safety and efficacy meet of exceed those of the U.S., being destroyed merely because of a difference in labels,” Hines notes.
“This has been a goal of Pharma and its allied front groups for more than 15 years during which time the continued predatory pricing practices of Pharma have made the U.S. into a safe haven for the highest prescription drug prices in the world.
“I respectfully urge the Secretary to order a delay in the implementation of Section 708—a move that is gaining support among Congress as it realizes the Section actually is contrary to what should be the goals of the FDA,” Hines continues.